Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen

Author:

Rizzieri David A.1,Long Gwynn D.1,Vredenburgh James J.1,Gasparetto Christina1,Morris Ashley1,Stenzel Timothy T.1,Davis Patti1,Chao Nelson J.1

Affiliation:

1. From the Marrow and Stem Cell Transplantation Program, Duke University Medical Center, Durham, NC.

Abstract

Abstract Reduction in the toxicity of allogeneic transplantation with nonmyeloablative induction regimens has expanded the scope of practice to older and more debilitated patients. However, the limited availability of matched sibling donors requires that alternative donor sources be investigated. Reported here are 2 cases of patients with advanced hematologic malignancies without matched siblings, partially matched family members, or matched unrelated donors who successfully underwent nonmyeloablative conditioning therapy followed by infusion of partially matched, unrelated-donor cord blood cells. The patients are in remission and remain 100% donor as assessed by short tandem repeat analysis of the marrow 6 and 12 months following transplantation.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference6 articles.

1. Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.;Laughlin;Leuk Res.,1998

2. Unrelated umbilical cord blood transplants in adult patients with hematologic malignancies or genetic disorders [abstract].;Long;Blood.,1999

3. Transplant lite: induction of graft versus malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies.;Khouri;J Clin Oncol.,1998

4. Induction of mixed chimerism and potent anti-tumor responses following non-myeloablative conditioning therapy and HLA-matched and mismatched donor bone marrow transplantation for refractory hematologic malignancies [abstract].;Spitzer;Blood.,1998

5. Chimerism-mediated immunotherapy using Campath T-cell depleted peripheral blood stem cells with non-ablative therapy provides reliable, durable allogeneic engraftment [abstract].;Rizzieri;Blood.,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3